Short report: 4-Aminopyridine—a new drug tested in the treatment of Eaton-Lambert syndrome
AUTOR(ES)
Lundh, H.
RESUMO
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492909Documentos Relacionados
- Novel drug of choice in Eaton-Lambert syndrome.
- Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.
- Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndrome
- Recurrent lobar pneumonia associated with idiopathic Eaton-Lambert syndrome.
- Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.
